4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001209191-22-020585
Chief Financial Officer acquired 6,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chardonnet Laurent Chief Financial Officer | 2022-03-21 | Grant or award | +6,500 | $7.51 | $48,815 | 14,500 | D |
Loading xslF345X03/doc4.xml…